Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori

Med Hypotheses. 2013 Nov;81(5):913-5. doi: 10.1016/j.mehy.2013.08.011. Epub 2013 Aug 22.

Abstract

Here we report a case of a 55-year Caucasian man, who improved the metabolic profile after the treatment for Helicobacter pylori eradication. In particular, we report the changes in homeostatic model assessment of insulin resistance, fatty liver index and echographic liver pattern. We hypothesize the co-factorial role of H. pylori in the mechanisms involved in non-alcoholic fatty liver disease pathogenesis and insulin resistance, by the cytokine serum changes. If this correlation is confirmed, the H. pylori treatment may represent an option in the clinical management of liver steatosis.

Publication types

  • Case Reports

MeSH terms

  • Alanine Transaminase / blood
  • Amoxicillin
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Blood Glucose
  • Clarithromycin
  • Cytokines / blood
  • Fatty Liver / drug therapy*
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori*
  • Humans
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Italy
  • Male
  • Metabolome / drug effects*
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease

Substances

  • Anti-Bacterial Agents
  • Blood Glucose
  • Cytokines
  • Insulin
  • Amoxicillin
  • Alanine Transaminase
  • Clarithromycin